Treatment of Salmonella paratyphi A osteomyelitis with trimethoprim-sulphamethoxazole.
D000293:Adolescent; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D005334:Fever; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D008297:Male; D009560:Niridazole / Q000627:therapeutic use; D010019:Osteomyelitis / Q000188:drug therapy*; D010270:Parasite Egg Count; D010279:Parathyroid Diseases / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use*; D012156:Reticulocytes / Q000032:analysis; D012548:Schistosoma haematobium / Q000302:isolation & purification; D012550:Schistosoma mansoni / Q000302:isolation & purification; D012552:Schistosomiasis / Q000188:drug therapy; D012785:Shoulder Joint; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D006454:Hemoglobins; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole; D009560:Niridazole